Douglas C. Lane & Associates’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-8,500
Closed -$277K 241
2014
Q3
$277K Sell
8,500
-800
-9% -$27.2K 0.01% 194
2014
Q2
$325K Sell
9,300
-3,550
-28% -$117K 0.01% 179
2014
Q1
$407K Sell
12,850
-15,325
-54% -$426K 0.01% 165
2013
Q4
$713K Sell
28,175
-5,999
-18% -$144K 0.02% 146
2013
Q3
$731K Sell
34,174
-6,940
-17% -$143K 0.03% 141
2013
Q2
$796K Buy
+41,114
New +$897K 0.03% 140

Other funds holding PTEN

Douglas C. Lane & Associates's PTEN Position: Q4 2014 in Review

Douglas C. Lane & Associates sold out of Patterson-UTI (PTEN) in Q4 2014, closing a stake of 8,500 shares — an estimated $277K sold.

Douglas C. Lane & Associates first reported a position in PTEN in Q2 2013 and held it in 6 quarters. The position peaked at $796K in Q2 2013. 270 funds tracked by Wall St. Rank hold PTEN as of Q4 2014.

  • Douglas C. Lane & Associates reported no remaining Patterson-UTI position as of Q4 2014 after selling out during the quarter.
  • Douglas C. Lane & Associates sold 8,500 Patterson-UTI shares in Q4 2014, an estimated $277K.
  • Douglas C. Lane & Associates first reported a position in Patterson-UTI in Q2 2013 and held it in 6 quarters.
  • Douglas C. Lane & Associates's Patterson-UTI position peaked at $796K in Q2 2013.
  • 270 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2014.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2014, filed 21 Jan 2015.